Chronic rhinosinusitis during immune checkpoint inhibition in melanoma patients
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela +3 more
wiley +1 more source
Multimodal AI and tumour microenvironment integration predicts metastasis in cutaneous melanoma. [PDF]
Andrew TW +11 more
europepmc +1 more source
This review provides an update on the epidemiology, pathogenesis, and clinical/histologic features of cutaneous leiomyosarcoma. Prognostic factors (e.g., depth of tumor involvement, grade, etc.) that can facilitate risk stratification are also discussed, as are treatment approaches for this rare malignancy.
Tejas P. Joshi +4 more
wiley +1 more source
ASO Author Reflections: Refining Prognosis in Stage III Cutaneous Melanoma with Non-nodal Regional Metastases. [PDF]
Riaz N, Bagge RO.
europepmc +1 more source
Scrotal squamous cell carcinoma: Two HPV‐negative cases with probable UV‐ induced pathogenesis
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Daniel Craus +7 more
wiley +1 more source
Tissue Resident Memory Cells: Friend or Foe?
Tissue‐resident memory T cells (TRM cells) are specialised immune cells in barrier tissues like the lungs, skin and gut, providing rapid host defence and tumour surveillance. Their retention and differentiation are regulated by molecules such as CD69, CD103 and TGF‐β. Dysregulation of TRM cells can lead to chronic activation, driving conditions such as
Chidimma F. Chude +2 more
wiley +1 more source
Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2 [PDF]
't Kint de Roodenbeke, Daphné +13 more
core
Survival impact of second primary cutaneous and non-cutaneous melanoma in melanoma survivors. [PDF]
Xie J, Kiuru M, Pollock BH, Keegan THM.
europepmc +1 more source
HPV125‐induced generalized verrucosis
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Sven Niklas Burmann +7 more
wiley +1 more source
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas
When questioning the effectiveness of adjuvant immunotherapy for acral melanomas, we found no clinical benefit to the adjuvant proposal, despite the maintenance of adverse effects. Abstract Background Solar factors play no role in the development of acral melanoma (AM). AM is characterized by low cumulative solar damage (low CSD).
Damien Sanogo +13 more
wiley +1 more source

